Recent Posts
- Ketamine Went From Psychiatry’s Great Hope to a Regulatory Reckoning, and 2026 Is the Shakeout. The Only FDA-Approved Version Sits Behind a Locked Door; Everything Else Is Off-Label.
- Nebraska Medicaid ABA Rates Hold Flat in SFY27 Because No Appropriation Was Made
- Florida ABA Task Force Opens Its Medicaid Review With a $6.57 Billion Spending Figure
- Benzodiazepines Are the Overdose Crisis No One Is Watching, and the Treatment System Was Never Built for Them. Street Benzos Meet Prescribed Users.
- Colorado Medicaid ABA Rates Are Pegged to 95 Percent of a Multi-State Benchmark That Includes Nebraska
Recent Comments
No comments to show.